Risk factors for resistance and MDR in community urine isolates: population-level analysis using the NHS Scotland Infection Intelligence Platform
Open Access
- 10 October 2017
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 73 (1) , 223-230
Abstract
Urinary tract infections (UTIs) are common. Antibiotic treatment is usually empirical, with the risk of under-treatment of resistant infections. To characterize risk factors for antibiotic-resistant community urine isolates using routine record-linked health data. Within the NHS Scotland Infection Intelligence Platform, national surveillance patient-level data on community urine isolates (January 2012–June 2015) were linked to hospital activity and community prescribing data. Associations between age, gender, comorbidity, care home residence, previous hospitalizations, antibiotic exposure and resistant (any antibiotic) or MDR (≥1 antibiotic from ≥3 categories) urinary isolates were quantified using multivariable logistic regression. Of 40984 isolates, 28% were susceptible, 45% were resistant and 27% were MDR. Exposure to ≥ 4 different antibiotics in the prior 6 months increased MDR risk (OR 6.81, 95% CI 5.73–8.11). MDR was associated with ≥29 DDD cumulative exposure, in the prior 6 months, for any antibiotic (OR 6.54, 95% CI 5.88–7.27), nitrofurantoin (OR 8.56, 95% CI 6.56–11.18) and trimethoprim (OR 14.61, 95% CI 10.53–20.27). Associations persisted for 10–12 months for nitrofurantoin (OR 2.31, 95% CI 1.93–2.76) and trimethoprim (OR 1.81, 95% CI 1.57–2.09). Increasing age, comorbidity, previous hospitalization and care home residence were independently associated with MDR. For resistant isolates the factors were the same, but with weaker associations. To our knowledge, we have demonstrated, using national capability at scale, the risk of MDR in community urine isolates for the first time and quantified the cumulative and sustained impact of antibiotic exposure. These data will inform the development of decision support tools for UTI treatment.Keywords
Funding Information
- Scottish Government
This publication has 16 references indexed in Scilit:
- Symptomatic treatment (ibuprofen) or antibiotics (ciprofloxacin) for uncomplicated urinary tract infection? - Results of a randomized controlled pilot trialBMC Medicine, 2010
- Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysisBMJ, 2010
- Association between Antimicrobial Consumption and Resistance in Escherichia coliAntimicrobial Agents and Chemotherapy, 2009
- Prior antibiotics and risk of antibiotic-resistant community-acquired urinary tract infection: a case–control studyJournal of Antimicrobial Chemotherapy, 2007
- The relationship between primary care antibiotic prescribing and bacterial resistance in adults in the community: a controlled observational study using individual patient dataJournal of Antimicrobial Chemotherapy, 2005
- Risk factors for antibiotic-resistant Escherichia coli isolated from community-acquired urinary tract infections in Dakar, SenegalJournal of Antimicrobial Chemotherapy, 2005
- Presence of bacteriuria caused by trimethoprim resistant bacteria in patients prescribed antibiotics: multilevel model with practice and individual patient dataBMJ, 2004
- Risk Factors for Antibiotic-Resistant Escherichia coli Isolated from Hospitalized Patients with Urinary Tract Infections: a Prospective StudyJournal of Clinical Microbiology, 2001
- Controversies in the laboratory diagnosis of community-acquired urinary tract infectionEuropean Journal of Clinical Microbiology & Infectious Diseases, 1993
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987